GlaxoSmithKline (CAI:BIOC) Other Current Payables: E£ Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is GlaxoSmithKline Other Current Payables?

GlaxoSmithKline CAI:BIOC -2.43% Other Current Payables is E£ Mil as of Mar. 2025.

GlaxoSmithKline's Other Current Payables for the quarter that ended in Mar. 2025 was E£ Mil.

GlaxoSmithKline Other Current Payables Related Terms

GlaxoSmithKline Other Current Payables Historical Data

* Premium members only.

The historical data trend for GlaxoSmithKline's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline Other Current Payables Chart

GlaxoSmithKline Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

GlaxoSmithKline Quarterly Data
Jun17 Sep17 Dec17 Mar18 Sep18 Dec18 Mar19 Jun19 Sep19 Mar20 Mar21 Jun21 Sep21 Mar22 Jun22 Mar23 Jun23 Sep23 Mar24 Mar25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

GlaxoSmithKline Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of E£ Mil mean?
GlaxoSmithKline (CAI:BIOC) has a Other Current Payables of E£ Mil as of Mar. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on GlaxoSmithKline and its competitors.
Is GlaxoSmithKline's Other Current Payables too high?
GlaxoSmithKline's current Other Current Payables is E£ Mil.
How does GlaxoSmithKline's Other Current Payables compare to PRPH?
GlaxoSmithKline's Other Current Payables of E£ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on GlaxoSmithKline and its competitors. GlaxoSmithKline's current Other Current Payables is E£ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlaxoSmithKline stock overvalued right now?
GlaxoSmithKline (CAI:BIOC) has a current Other Current Payables of E£ Mil. The current Other Current Payables is E£ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For GlaxoSmithKline (CAI:BIOC), the current Other Current Payables is E£ Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlaxoSmithKline Business Description

Address Boomerang Building, No 46, Block (J) First Section City Centre, Town Centre, Second floor, Fifth District - New Cairo, Cairo, EGY, 11835
GlaxoSmithKline is a pharmaceutical company. It is focused on developing new medicines in respiratory, HIV, oncology, and immune-inflation. The company is segmented into Commercial Operations and Total Research and development. It generates the majority of its revenue from the Commercial Operations segment.